Hospitals Sue HHS Over 340B Pilot Program Changes
Hospitals challenge HHS's 340B pilot shifting drug discounts to a rebate system, citing financial risks and regulatory concerns.
CMS to Revise Medicare Hospital Payment Weights Using Market-Based Data for FY2029
CMS plans to change Medicare hospital payment weights methodology using Medicare Advantage data starting FY2029, impacting hospital reimbursement and clinical documentation.
Medicare Drug Price Negotiations Expand to 15 More Medications in 2027
CMS expands Medicare drug price negotiations to 15 more medications starting in 2027, including popular diabetes and weight loss treatments, aiming to reduce prescription costs and save Medicare billions.
CMS Launches Voluntary Medicaid MFN Drug Pricing Model; Trump-Era Manufacturer Agreements Expand
CMS unveils the GENERous Medicaid payment model introducing MFN drug pricing, alongside expanded Trump administration drug pricing agreements and key regulatory updates for 2026.
FDA Approves Leucovorin for Autism Amid Investment and Regulatory Clarifications
FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.
Medicare Fraud, Organ Recovery Oversight, and Youth Fitness Legislation Shape U.S. Healthcare Policy
Recent U.S. healthcare updates cover a $34.8M Medicare fraud case, HHS action on organ recovery agency safety, youth fitness legislation, and ACIP's hepatitis B vaccine deliberations.
CMS Pilot Uses AI for Medicare Prior Authorization, Faces Oversight Calls
CMS launches AI-driven pilot to streamline Medicare prior authorization for select services, prompting legislative calls for independent oversight to ensure patient safety and regulatory compliance.
Medicare Launches AI-Driven Pilot to Review Medical Procedure Approvals
Medicare initiates an AI-based pilot program to aid in approving or denying certain medical procedures, raising considerations about healthcare administrative processes and payer-provider dynamics.
Federal Judge Blocks Key Trump-Era ACA Rule Provisions Impacting Coverage
A federal judge blocks major Trump-era ACA provisions that could lead to 1.8 million losing coverage, citing regulatory overreach and increased health costs.
UnitedHealth Faces DOJ Scrutiny Over Medicare Advantage as Industry Faces AI and Market Shifts
UnitedHealth Group responds to DOJ investigations into Medicare Advantage amid broader insurance market changes including AI automation and pharmaceutical supply dynamics.